Logo

CombiMatrix Starts Trading on Nasdaq Global Market

Nov 19, 2007
NEW YORK (GenomeWeb News) – CombiMatrix’s stock began trading on the Nasdaq Global Market today.
 
The stock had been trading on the Nasdaq Capital Market since CombiMatrix split off from its former parent company Acacia Research in August.
 
CombiMatrix, which now trades under the symbol CBMX, was trading at $6.77 a share late Monday afternoon.
 

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.